Condition: Cardiogenic Shock · Acute Myocardial Infarction · Multi Vessel Coronary Artery Disease · Sponsor: Samsung Medical Center
This study is a prospective, open-label, two-arm, randomized multicenter trial to identify whether immediate multi-vessel PCI would be better in clinical outcomes compared with culprit lesion-only PCI for AMI and multi-vessel disease with an advanced form of CS patients who require veno-arterial extracorporeal membrane oxygenator (VA-ECMO).
This description comes directly from the study's public registry record.
Jeong Hoon Yang, MD · 82-2-3410-3419 · jhysmc@gmail.com
Ki Hong Choi, MD · 82-2-3410-6653 · cardiokh@gmail.com
Always discuss trial participation with your own doctor first.
| Samsung Medical Center | Seoul, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05527717